Esperion Therapeutics | ESPR - Créances Commerciales





Créances Commerciales Changement Date
AbbVie USD 12.59B 180M 2025-12
Alnylam Pharmaceuticals USD 883.96M 106.39M 2026-03
Alterity Therapeutics Limited AUD 4.57M 1.42M 2025-12
Amarin USD 126.83M 477K 2025-12
Amgen USD 9.14B 432M 2026-03
Biogen USD 1.79B 76.6M 2026-03
BioMarin Pharmaceutical USD 903.91M 4.3M 2026-03
Cipla INR 62.19B 12.42B 2026-03
CSL USD 4.32B 1.35B 2025-12
Cytokinetics USD 6.83M 10.94M 2026-03
Daiichi Sankyo JPY 695.95B 79.1B 2025-12
Eli Lilly USD 21.18B 1.02B 2026-03
Esperion Therapeutics USD 140.19M 21.21M 2025-12
Geron USD 39.23M 1.57M 2025-12
Grifols EUR 1B 285.88M 2025-12
Halozyme Therapeutics USD 457.99M 16.72M 2026-03
Heron Therapeutics USD 89.59M 8.54M 2025-12
Ionis Pharmaceuticals USD 74M 8M 2026-03
Merck USD 11.78B 345M 2025-12
Moderna USD 71M 113M 2026-03
Nektar Therapeutics USD 1.78M 1.12M 2025-12
Pfizer USD 16.17B 332M 2026-03
PTC Therapeutics USD 181.62M 21.45M 2025-12
Puma Biotechnology USD 28.1M 3.52M 2024-06
Regeneron Pharmaceuticals USD 5.73B 10.1M 2026-03
Sanofi EUR 482M 85M 2026-03
Sarepta Therapeutics USD 547.91M 149.68M 2026-03
United Therapeutics USD 312M 38.2M 2026-03
Vanda Pharmaceuticals USD 47.1M 4.35M 2024-12